Gone Tripping: United CEO Scott Kirby & Psychedelic Therapy 4/22/26

Squawk Pod

CNBC

Business News, News, Investing, Business

4.2 • 543 Ratings

🗓️ 22 April 2026

⏱️ 36 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

United Airlines CEO Scott Kirby discusses his company’s latest financial report and responds to President Trump’s comments on a potential United-American merger. Plus, an executive order on medical treatments for serious mental health issues bumped psychedelics stocks higher. Psychedelics investor and founder Christian Angermayer explains the industry’s opportunity for mental health–and for investors. Dan Murphy Scott Kirby & Phil LeBeau - 15:13 Christian Angermayer - 30:21 In this episode: Christian Angermayer, @C_Angermayer Dan Murphy, @dan_murphy Phil LeBeau, @Lebeaucarnews Becky Quick, @BeckyQuick Joe Kernen, @JoeSquawk Andrew Ross Sorkin, @andrewrsorkin Katie Kramer, @Kramer_Katie

Transcript

Click on a timestamp to play from that location

0:00.0	bring in show music please
0:02.5	Hi, I'm CNBC producer Katie Kramer.
0:07.2	Today on Squawk Pod, a couple of trips coming your way.
0:11.9	We're taking off with United CEO Scott Kirby.
0:15.0	He responds to President Trump, who said right on CNBC
0:18.3	that he would not support a merger between United and American Airlines.
0:23.5	We have not at United commented on all the, I know there's lots of rumors, lots of stories about
0:28.1	consolidation. We've not commented, and I'm not going to start that today.
0:31.6	And when surging jet fuel prices could hit your ticket fares.
0:35.9	We are passing through right now about 40 to 50% of the increase of fuel.
0:39.3	It's faster than I can ever remember in my career.
0:42.3	And we expect to get to 100% by the end of year.
0:45.3	It does have some impact this year.
0:47.3	Then flying high in a metaphysical kind of way.
0:50.3	An executive order from the president pushed psychedelic stocks a little higher.
0:55.8	Investor Christian Engremire explains the opportunity.
0:59.1	Psychedelics are amazing and wonderful therapeutics, but they are very strong, positively strong.
1:06.0	That's why they actually have a responder rate in the clinical trials for the worst cases of treatment-resistant
1:13.1	depression, addiction, anxiety disorders, whatever, of up to 80%.
1:18.8	It's a trip.
1:20.1	I've grew up in the 70s. I'm not going to say anything more than that.
1:24.1	Plus, the confirmation hearing for the next Fed chair, and following President Trump's comments to us,
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.